Siemens Healthineers AG

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.

TARRYTOWN, N.Y.--(BUSINESS WIRE)--The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer1 for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world's major markets. Labs operating at low to medium testing volumes will benefit from competitive advantages that the analyzer offers, including improved turnaround time predictability, advanced reporting functionality, and focused safe.

Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges

Siemens Healthineers has been re-rated in recent months, as easing supply chain headwinds allow it to address the growing backlog. But expectations are high now, with the near-term guidance reaffirmed despite quarterly earnings numbers falling short. Further write-downs of the outsized goodwill balance pose additional downside risk to future earnings.

Siemens Healthineers: Still An Interesting MedTech Name But Now At A Premium

MONROE TOWNSHIP, N.J., OXFORD, England & MALVERN, Pa.--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, and PETNET Solutions Inc, A Siemens Healthineers Company, today announced the commercial availability of POSLUMA® (flotufolastat F 18) in the United States. POSLUMA (formerly referred to as to as 18F-rhPSMA-7.3) is an optimized, high-affinity radiohybrid (rh) Prostate-Specific Membr.

Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company, Announce U.S. Commercial Availability of POSLUMA® (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer

I looked at Siemens Healthineers in my last article back in March, which makes it suitable for an update at this time. Siemens Healthineers remains a solid company to look at for long-term investment - even if the company has outperformed and is more expensive now than before. I remain at a "BUY" on Healthineers - albeit at a somewhat reduced upside next to where I was a few months back.

Siemens Healthineers: Still A Company Worth Looking At

Siemens Healthineers AG (OTCPK:SEMHF) Q2 2023 Earnings Conference Call May 10, 2023 2:30 AM ET Company Participants Marc Koebernick - Head, Investor Relations Bernhard Montag - Chief Executive Officer Jochen Schmitz - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Graham Doyle - UBS Odysseas Manesiotis - Berenberg Falko Friedrichs - Deutsche Bank Robert Davies - Morgan Stanley Sezgi Oezener - HSBC Operator Good morning, ladies and gentlemen, and welcome to Siemens Healthineers Conference Call. As a reminder, this conference is being recorded.

Siemens Healthineers AG (SEMHF) Q2 2023 Earnings Call Transcript

WASHINGTON--(BUSINESS WIRE)--A partnership between Siemens, Siemens Healthineers, and the University of California, San Francisco has proven medical centers can achieve significant carbon reduction and cost savings by turning off or putting MRIs into the lowest power setting when not in use. The findings, featured in a new Radiology study, can help the healthcare sector meaningfully reduce its carbon footprint, one that accounts for 4.4% of global carbon emissions. Working in tandem with UCSF,.

Siemens, Siemens Healthineers and UCSF research partnership proves significant energy, cost and emission reduction in MRI machine operation

ATLANTA--(BUSINESS WIRE)--Cognosos – a leading provider of real-time location services (RTLS)–today announced it has been selected by Siemens Healthineers to provide real-time asset tracking and intelligence for hospitals and healthcare systems. With this strategic relationship, Siemens Healthineers becomes an important reseller of the Cognosos portfolio of products and services.

Cognosos to Provide Siemens Healthineers with Next-Generation Technology to Power Real-Time Location Services for its Customer Network of Hospitals and Healthcare Facilities

I've often reviewed Siemens as a business - and also written about some of its various arms, but not reviewed Healthineers as of yet. This changes today. I'm going to be reviewing Siemens Healthineers and discuss its attraction as an investment.

Siemens Healthineers: Undervalued Quality, To Some Degree

HAMAMATSU, Japan , March 6, 2023 /PRNewswire/ -- Hamamatsu, a leading manufacturer of photonics devices, including whole slide scanners for digital pathology, today announced a multi-year distribution agreement with Siemens Healthineers. Under the agreement, Hamamatsu will provide NanoZoomer* whole slide scanners to support Siemens Healthineers expansion into digital pathology in the Americas and Europe.

Hamamatsu and Siemens Healthineers announce the distribution of the whole slide scanners to clinical markets

Hospital capital spending demand is strong, but Siemens Healthineers posted a small yet broad miss across its major business units for the fiscal first quarter. Imaging is performing well and Varian and Advanced Therapies were compromised by supply chain challenges, but core underperformance in Diagnostics is an ongoing issue.

Siemens Healthineers: Robust Equipment Demand, But With Some Ongoing Internal Challenges

Siemens Healthineers AG (OTCPK:SEMHF) Q1 2023 Earnings Conference Call February 2, 2023 2:30 AM ET Company Participants Marc Koebernick - Head of Investor Relations Bernd Montag - Chief Executive Officer Jochen Schmitz - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Veronika Dubajova - Citi Graham Doyle - UBS David Adlington - JPMorgan Sezgi Oezener - HSBC Robert Davies - Morgan Stanley Operator Good morning, ladies and gentlemen, and welcome to Siemens Healthineers Conference Call. As a reminder, this conference is being recorded.

Siemens Healthineers AG (SEMHF) Q1 2023 Earnings Call Transcript

Siemens Healthineers AG expects strong growth in both revenue and earnings per share through fiscal 2025. The company pays a dividend and buys back shares; the dividend yield is currently about 1.9% and the dividend per share increased 12% over the past year.

Siemens Healthineers: Valuation Too High

General Electric

Medtronic

Siemens Healthineers AG and General Electric Co's healthcare business are weighing a potential acquisition of two units being spun off by Medtronic Plc, Bloomberg news reported on Thursday, citing people familiar with the matter.

Siemens Healthineers, GE Healthcare eye Medtronic units - Bloomberg News

CHARLOTTE, N.C. & MALVERN, Pa.--( BUSINESS WIRE )--Siemens Healthineers and Atrium Health, a leading nonprofit health provider known for its top-ranked pediatric, cancer and heart care programs, have announced a multi-year Value Partnership1 agreement. This strategic agreement will focus on driving access to care in Atrium Health's service region across the southeastern U.S., improving health equity and enhancing economic mobility. Atrium Health will purchase $140 million in Siemens Healthineers devices and equipment, including advanced imaging technology, radiation oncology and precision endovascular robotics.

Siemens Healthineers, Atrium Health Enter Multi-Year Value Partnership to Improve Health Care Capabilities, Access and Equity

Siemens Healthineers AG (OTCPK:SEMHF) Q4 2022 Earnings Conference Call November 9, 2022 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernd Montag - President, CEO and Chairman Jochen Schmitz - CFO Conference Call Participants Hassan Al-Wakeel - Barclays David Adlington - JPMorgan James Vane-Tempest - Jefferies Graham Doyle - UBS Julien Dormois - BNP Paribas Exane Veronika Dubajova - Citi Odysseas Manesiotis - Berenberg Robert Davies - Morgan Stanley Falko Friedrichs - Deutsche Bank Sezgi Oezener - HSBC Ed Ridley-Day - Redburn Operator Good morning, ladies and gentlemen, and welcome to Siemens Healthineers' Conference Call. As a reminder, this conference is being recorded.

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q4 2022 Results - Earnings Call Transcript

Siemens Healthineers on Wednesday posted rising earnings and revenue for the fourth quarter of its fiscal year that beat expectations, driven by the imaging division.

Siemens Healthineers posts forecast-beating earnings and revenue, driven by imaging division

Paris, France – October 2 6 th , 202 2 – Atos today announces the win of a seven-year contract with Siemens Healthineers to provide, deploy and manage Software Defined Access (SDA)-enabled global LAN (local area network) services in close to 60 customer locations in 15 countries. This contract showcases Atos' ability and commitment, as global network infrastructure partner, to support Siemens Healthineers on its journey towards a modernized and independent LAN network based on Cisco SDA.

Atos to deploy and manage intelligent network for Siemens Healthineers with seven-year contract

Corindus Vascular Robotics

NEWTON, Mass.--(BUSINESS WIRE)--Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular System. The data represents a milestone in the company's commitment to extending precision robotics into neurovascular treatment. The prospective, single-arm, intern

Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System

Siemens Healthineers underwhelmed in its latest quarterly earnings report amid the ongoing supply-side challenges. Given the earnings headwinds are transitory rather than structural, the long-term investment case remains intact.

Siemens Healthineers: Looking Through The Short-Term Headwinds

Siemens Healthineers AG (OTCPK:SEMHF) Q3 2022 Earnings Conference Call August 3, 2022 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernhard Montag - President, CEO & Chairman Jochen Schmitz - CFO Conference Call Participants Patrick Wood - Bank of America Merrill Lynch Hassan Al-Wakeel - Barclays Bank David Adlington - JPMorgan Chase & Co. Daniel Wendorff - ODDO Odysseas Manesiotis - Berenberg Graham Doyle - UBS Edward Ridley-Day - Redburn Julien Dormois - BNP Paribas Exane Sezgi Oezener - HSBC Falko Friedrichs - Deutsche Bank Operator [Technical Difficulty]. Marc Koebernick Thank you, operator, and good morning, dear analysts and investors.

Siemens Healthineers AG (SEMHF) CEO Bernhard Montag on Q3 2022 Results - Earnings Call Transcript

U.S.-German medical device maker Siemens Healthineers stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quarters.

Siemens Healthineers Q3 earnings fall, confirms 2022 outlook

MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed at advancing personalized medicine and improving access to high quality, cost-effective healthcare. Through the five-year strategic partnership, Siemens Healthineers and Varian, a Siemens Healthineers company, will provide comprehensive technology and services that will build on previous successful collaborative projects. The university and medical center will

Siemens Healthineers and The Ohio State University Wexner Medical Center Announce Strategic Partnership Focused on Personalized Medicine and Increased Access to High Quality Healthcare

Siemens Healthineers AG is a subsidiary of Siemens AG and a leading medical technology company. The company designs, develops, manufactures and markets sophisticated healthcare solutions for a broad range of customers such as clinics/hospitals, physicians, universities, etc.

Siemens Healthineers: Solid, But No Buy Recommendation

Siemens Healthineers AG (OTCPK:SEMHF) Q2 2022 Earnings Conference Call May 4, 2022 2:00 AM ET Company Participants Marc Koebernick - IR Bernd Montag - CEO Jochen Schmitz - CFO Conference Call Participants Patrick Wood - Bank of America Veronika Dubajova - Goldman Sachs Julien Dormois - Exane Will Mackie - Kepler Odysseas Manesiotis - Berenberg Kate Kalashnikova - Citi Daniel Wendorff - ODDO Sezgi Oezener - HSBC Operator Good morning, ladies and gentlemen, and welcome to Siemens Healthineers' Conference Call. As a reminder, this conference is being recorded.

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q2 2022 Results - Earnings Call Transcript

U.S.-German medical device maker Siemens Healthineers raised its 2022 targets on Wednesday due to increased demand for rapid COVID-19 antigen tests, and reported a rise in first-quarter revenue and earnings.

News for Siemens Healthineers AG Stock (SMMNY)